Agenda:

Pharmaceutical and Therapeutics Committee

June 4, 2010
9:00 a.m.

Meeting Site:
Texas Department of Aging & Disability Services
Winters Building
Public Hearing Room
701 West 51st Street
Austin, TX

1. Call to Order
   
   
2. Approval of Minutes from February 26, 2010
   
   
3. Old Business
• Report on HHSC decisions on acceptance of the Pharmaceutical & Therapeutics Committee recommendations from the February 26, 2010 meeting.
  
  
4. New Business

   Public Comment on Drug Classes to be reviewed for the Medicaid PDL (Drug Classes Listed Below)

   • Anticoagulants, Injectable
     
   • Platelet Aggregation Inhibitors
     
   • Lipotropics, Statins
     
   • Lipotropics, Other
     
   • Beta-Blockers
     
   • Angiotensin Modulators
     
   • Calcium Channel Blockers
     
   • Angiotensin Modulator Combinations
     
   • Pulmonary Arterial Hypertension (PAH) Agents, Oral and Inhaled
     
   • Glucocorticoids, Inhaled ( Pended from February Meeting)
     Cough and Cold, Cold
     Cough and Cold, Narcotic
     Cough and Cold, Non-Narcotic
     
   • Proton Pump Inhibitors
     
   • Antiemetics
     
   • Ulcerative Colitis Agents
     
   • Pancreatic Enzymes
     
   • Bile Salts

   Public Comment on new drugs to be reviewed for the Medicaid PDL (Drugs Listed Below)

   • Antihyperuricemics
     Colcrys
     
   • Cytokine and Cam Antagonists
     Actemra
     Stelara
     
   • Non Steroidal Anti-Inflammatory Drugs
     Zipsor
     
   • Analgesics, Narcotic - Short Acting
     Onsolis
     
   • Analgesics, Narcotic - Long Acting
     Embeda
     
   • Antiparkinson's Agents
     Mirapex ER
     
   • Antifungals, Oral
     Terbinex
     
   • Ophthalmics, Anti-Inflammatories
     Acuvail
     
   • Ophthalmics for Allergic Conjunctivitis
     Bepreve
     
   • Hypoglycemics, Incretin Mimetics/Enhancers
     Victoza

5. Therapeutic and Clinical Drug Reviews (Drug Classes and New Drugs Listed Above)- Steve Liles, Pharm.D., Provider Synergies, LLC

6. Executive Work Session

7. Announcements of Drugs Recommended for the Medicaid Preferred Drug List

8. Adjourn

9. Next Meeting Date – August  20, 2010

This meeting is open to the general public.  No reservations are required and there is no cost to attend this meeting.  For more information please contact:  Amanda Fay (amanda.fay@hhsc.state.tx.us ) Medicaid/CHIP Division, 512-491-4012.

Persons with disabilities who wish to attend the meeting and require auxiliary aids or services should contact Amanda Fay at least 72 hours prior to the meeting so that appropriate arrangements can be made.